- Email: [email protected]
Guidelines for Authors
NEWS 10
Association News • • • •
APhA Reorganizes to Meet Member Needs Caro Assumes Senior Director Post Murer Is 1990-91 Executive Resident Thank You, Burroughs Wellcome
13
Legislation and Regulation • • • •
10
Association News
Guidelines for Authors American Pharmacy welcomes manuscripts that report on significant practice developments and that are written in a crisp, concise style. These papers may concern the introduction of new knowledge regarding roles, technologies, methods, drugs, and therapeutic trends. All manuscripts are subject to review by qualified outside reviewers . Documentation is required , and illustrations are welcomed. Authors must conform to American Pharmacy's style on listing references; please consult a recent issue for guidance. Through the journal, you can share your views, concerns, findings, and ideas with your colleagues. Material is accepted for the following departments: • Feature articles (1,200 words or more) on subjects of broad interest to the profeSSion. • Reviewed research reporting on original research. • Reviewed reports reviewing topics germane to pharmacy. • Viewpoint articles (700 - 1,000 words) expressing opinion or commentary on topics of interest to pharmacists. Counterpoint submissions are welcomed. • Letters to the Editor (200 words or less) either responding to material in .the journal or commenting on issues of interest to pharmacists. • Member items (50 words or less) describing the achievements of APhA members. • Calendar items providing specific information on upcoming events (continuing education programs, meetings, etc .). Please submit at least 12 weeks in advance of the month in which you want the information published . Manuscripts must be double-spaced. The original and two copies must be submitted. Illustrations should be at least 5 x 7 inch glossy photographs; legible line art; or typed, error-free charts or graphs.
4
FDA Asks Sandoz to Change Clozapine's Restrictive Labeling Stark Introduces Bill to Slow Drug Inflation NRC Changes Rule in Favor of Pharmacists' Rights Should FDA Become an Independent Agency?
15
Practice Trends • Program Helps Pharmacists Assess Their Learning Needs • Americans Disagree About National Health Coverage • Guidelines Released for Handling Hazardous Drugs
16
Patient Counseling • Many Adults Not Immunized Adequately, ACP Says • This Month's Health Promotions
18
Drug Research • • • •
Some Beta and Calcium Blocker Combinations Could Be Harmful Diabetes Screening Tests May Find Disease Verapamil Boosts the Effectiveness of Chemotherapy Research May Yield Drug Treatments for Multiple Sclerosis
DEPARTMENTS Guidelines for Authors Message from Headquarters Letters From the Literature
4 7
8 59
Calendar Members Classified Leadership Forum
61
63 63 64
American Pharmacy, Vol. NS30, No. 10 October 1990/564
Association News • • • •
APhA Reorganizes to Meet Member Needs Caro Assumes Senior Director Post Murer Is 1990-91 Executive Resident Thank You, Burroughs Wellcome
13
Legislation and Regulation • • • •
10
Association News
Guidelines for Authors American Pharmacy welcomes manuscripts that report on significant practice developments and that are written in a crisp, concise style. These papers may concern the introduction of new knowledge regarding roles, technologies, methods, drugs, and therapeutic trends. All manuscripts are subject to review by qualified outside reviewers . Documentation is required , and illustrations are welcomed. Authors must conform to American Pharmacy's style on listing references; please consult a recent issue for guidance. Through the journal, you can share your views, concerns, findings, and ideas with your colleagues. Material is accepted for the following departments: • Feature articles (1,200 words or more) on subjects of broad interest to the profeSSion. • Reviewed research reporting on original research. • Reviewed reports reviewing topics germane to pharmacy. • Viewpoint articles (700 - 1,000 words) expressing opinion or commentary on topics of interest to pharmacists. Counterpoint submissions are welcomed. • Letters to the Editor (200 words or less) either responding to material in .the journal or commenting on issues of interest to pharmacists. • Member items (50 words or less) describing the achievements of APhA members. • Calendar items providing specific information on upcoming events (continuing education programs, meetings, etc .). Please submit at least 12 weeks in advance of the month in which you want the information published . Manuscripts must be double-spaced. The original and two copies must be submitted. Illustrations should be at least 5 x 7 inch glossy photographs; legible line art; or typed, error-free charts or graphs.
4
FDA Asks Sandoz to Change Clozapine's Restrictive Labeling Stark Introduces Bill to Slow Drug Inflation NRC Changes Rule in Favor of Pharmacists' Rights Should FDA Become an Independent Agency?
15
Practice Trends • Program Helps Pharmacists Assess Their Learning Needs • Americans Disagree About National Health Coverage • Guidelines Released for Handling Hazardous Drugs
16
Patient Counseling • Many Adults Not Immunized Adequately, ACP Says • This Month's Health Promotions
18
Drug Research • • • •
Some Beta and Calcium Blocker Combinations Could Be Harmful Diabetes Screening Tests May Find Disease Verapamil Boosts the Effectiveness of Chemotherapy Research May Yield Drug Treatments for Multiple Sclerosis
DEPARTMENTS Guidelines for Authors Message from Headquarters Letters From the Literature
4 7
8 59
Calendar Members Classified Leadership Forum
61
63 63 64
American Pharmacy, Vol. NS30, No. 10 October 1990/564